|
Catalog Number 606S255X |
Device Problem
Physical Resistance/Sticking (4012)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/05/2023 |
Event Type
malfunction
|
Event Description
|
The healthcare professional reported that during a stent-assisted endovascular embolization procedure, the stent was impeded in the distal end of the prowler select plus microcatheter (606s255x / 31028213) (the stent did not enter the vessel) and could not pass through the microcatheter.The physician removed the microcatheter and the stent from the patient and replaced the microcatheter to complete the procedure using the original stent.There was no report of any negative patient impact.On 14-dec-2023, additional information was received.The information indicated that the target vessel was the right internal carotid artery (ica) terminus with normal vessel curvature.A 4mm x 23mm no tip enterprise¿ 2 vascular reconstruction device (encr402300 / lot# unknown) was used.No other devices were successfully used with the microcatheter prior to or after the reported resistance was encountered.There was no device damage noted at any time.Nothing was noted to be obstructing the microcatheter.A continuous flush was maintained through the microcatheter.The introducer was flushed until liquid was visible at the distal end of the slit in the clear tube.The tip of the introducer was firmly installed into the hub of the microcatheter and locked with the rotating hemostasis valve (rhv) during the device advancement.Based on the additional information received on 14-dec-2023, the reported event has been deemed usfda reportable under 21 cfr 803 with a classification of ¿malfunction.¿.
|
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.Section e.1: the initial reporter phone: (b)(6).The initial reporter email address was not available / reported.Section e.1: initial reporter facility name: (b)(6).Section h.3: the device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.A review of manufacturing documentation associated with this lot (31028213) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no nonconformances related to device manufacture or inspection.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to report the investigation finding of the returned device.The complaint device was returned for evaluation and analysis.The investigation finding is documented below.Investigation summary: a non-sterile prowler select plus microcatheter was received contained in the decontamination pouch.Visual inspection was performed.No appearance of damages were observed.Microscopic inspection was performed along the body of the prowler select plus microcatheter.No damages were observed under magnification.The device was flushed with a laboratory sample syringe.After flushing, a lab sample enterprise system was introduced into the microcatheter and it was able to be advanced through the entire length of the microcatheter without noticeable resistance.The inner diameter (id) and outer diameter (od) of the device were measured and confirmed to be within specifications.A review of manufacturing documentation associated with this lot (31028213) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no nonconformances related to device manufacture or inspection.As part of cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.The enterprise system was able to pass through the entire length of the microcatheter without significant resistance, even through the distal portion.Additionally, no other damages were found on the microcatheter that could have contributed to the issue reported during the procedure.The reported issue documented in the complaint cannot be confirmed with the evidence available.It is possible that other clinical and procedural factors that cannot be replicated during the analysis may have contributed to the reported failure.The instructions for use (ifu) contains the following caution: if strong resistance is met during manipulation, discontinue the procedure, and determine the cause of resistance before proceeding.If the cause of resistance cannot be determined, withdraw the catheter and guidewire as a system.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to report that the product was received in the product analysis lab on (b)(6) 2024.The returned product is pending evaluation.A supplemental 3500a report will be submitted once the product investigation has been completed.Updated sections: b.4, d.9, g.3, g.6.H.2, h.3, h.6, and h.10.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Search Alerts/Recalls
|
|
|